Home » Topics » Regulatory » Patents

Patents
RSS

Potent anti-MRSA agents developed by Sankyo

Dec. 4, 1998

New SERMS from Lilly

Dec. 4, 1998

Astra patents new pyrazolopyrimidinedione immunosuppressants

Dec. 4, 1998

Heterocyclic melatonergic agents designed at ADIR

Dec. 4, 1998

New HIV protease inhibitors in development at Monsanto

Dec. 3, 1998

Agents for ulcers synthesized and evaluated at Shiseido

Dec. 3, 1998

American Home Products describes preferential COX-2 inhibitors

Dec. 3, 1998

Taisho discloses new antitumor series

Dec. 2, 1998

Inhibitors of neovascularization (angiogenesis) patented by JT

Dec. 2, 1998

Piperidine derivatives from Sanofi useful for neurokinin-dependent pathologies

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.